Universe Pharmaceuticals ... (UPC)
NASDAQ: UPC
· Real-Time Price · USD
3.52
-0.04 (-1.12%)
At close: Aug 15, 2025, 1:44 PM
Universe Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 |
Net Income | 1.09M | -8.73M | -18.55M | -6.16M | -9.45M | -7M | 5.9M | 11.32M | 10.93M |
Depreciation & Amortization | 506.51K | 485.73K | 499.87K | 508.79K | 484.17K | 518.5K | 495.52K | 446.88K | 448.5K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | -6.26M | -7.86M | -5.47M | -3.87M |
Other Working Capital | -1.86M | -2.14M | 1.87M | 1.62M | -3.68M | 7.34M | 5.11M | -8.11M | -2.38M |
Other Non-Cash Items | -10.23M | 186.19K | 10.18M | -488.38K | -444.46K | 5.45M | 7.3M | 5.24M | 3.6M |
Deferred Income Tax | -58.44K | 606.7K | 787.87K | 679.59K | -41K | -698.27K | -839.97K | -668.34K | 66.28K |
Change in Working Capital | 4.17M | -2.06M | 1.02M | 6.62M | 6.35M | 6.21M | -1.76M | -12.69M | -7.06M |
Operating Cash Flow | -4.52M | -9.51M | -6.07M | 1.16M | -3.1M | -1.78M | 3.24M | -1.82M | 4.12M |
Capital Expenditures | -392.21K | -363.09K | -111.18K | -44.17K | -38.72K | -93.7K | -13.54M | -13.53M | -76.77K |
Cash Acquisitions | n/a | n/a | n/a | n/a | -15 | 523.00 | 26.62M | 26.62M | n/a |
Purchase of Investments | 313.54K | n/a | -313.54K | n/a | n/a | n/a | -15.33M | -15.33M | n/a |
Sales Maturities Of Investments | -313.54K | n/a | 313.54K | n/a | n/a | n/a | 1.8M | 1.8M | n/a |
Other Investing Acitivies | -115.49K | -115.49K | n/a | n/a | -3.81M | -3.81M | -26.62M | -26.62M | n/a |
Investing Cash Flow | -426.37K | -361.29K | -111.18K | -44.17K | -3.85M | -3.91M | -27.06M | -27.06M | -76.77K |
Debt Repayment | 10.35M | 8.95M | n/a | n/a | 3.34M | 3.34M | -1.57M | 624.35K | 2.19M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -6.07M | n/a | 2.6M | -1.39M | 2.08M | -19.99K | -2.81M | -2.79M | 235.07K |
Financial Cash Flow | 44.28M | 33.95M | 2.6M | -1.39M | 5.42M | 3.32M | 2.43M | 26.58M | 24.37M |
Net Cash Flow | 38.41M | 24.21M | -4.09M | -426.21K | -1.28M | -2.37M | -21.76M | -2.78M | 26.86M |
Free Cash Flow | -4.91M | -9.87M | -6.18M | 1.11M | -3.14M | -1.88M | -10.29M | -15.35M | 4.04M |